Tannic Acid and Vitamin D Composition for Elastin Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for tissue damage, such as sun damage or age-related issues, often inhibit elastin formation, leading to decreased skin elasticity and tissue health, despite providing moisturizing benefits.
Innovation Solution
A composition comprising a first agent that blocks elastin production and a second agent that promotes elastin production, with the second agent present at a concentration of 0.1 nM to 100 nM, including polyphenols like tannic acid and moisturizing agents like hyaluronic acid or vitamin D, to neutralize the blocking effect and enhance elastin formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If moisturizing agents (such as vitamin D, hyaluronic acid, or ferulic acid) are used to treat tissue damage, then moisturizing benefits are provided, but elastin production is blocked
Solution Approach 1:
Tannic acid serves as an intermediary substance that mediates between the moisturizing agents and elastin production. It neutralizes the blocking effect of vitamin D, hyaluronic acid, or ferulic acid on elastin production, allowing both moisturizing benefits and elastin formation to coexist. The tannic acid interacts with the moisturizing agents to prevent their inhibitory effect on elastin synthesis.
Solution Approach 2:
The invention converts the harmful blocking effect of moisturizing agents on elastin production into a beneficial outcome. By adding tannic acid, the previously harmful interaction (moisturizing agent blocking elastin) is transformed into a useful effect (enhanced elastin production while maintaining moisturizing benefits). The tannic acid redirects the interaction to produce both desired effects simultaneously.
2Quantity of substance
If treatments block elastin production, then moisturizing benefits are achieved, but skin elasticity decreases
Solution Approach 1:
Tannic acid acts as a mediator that enables the coexistence of moisturizing effects and skin elasticity. It interferes with the mechanism by which moisturizing agents block elastin production, thereby preserving skin elasticity while maintaining the moisturizing benefits of the treatment.
Solution Approach 2:
The invention changes the chemical or biological parameters of the treatment system by introducing tannic acid. This parameter change (adding tannic acid to the composition) alters the interaction dynamics between moisturizing agents and elastin production pathways, resulting in improved skin elasticity without sacrificing moisturizing effects.
3Strength
If elastin production is enhanced by adding tannic acid, then skin elasticity improves, but treatment complexity increases
Solution Approach 1:
Tannic acid serves multiple functions simultaneously: it enhances elastin production, neutralizes the blocking effect of moisturizing agents, and maintains skin elasticity. This multi-functionality reduces the need for separate treatment components, as tannic acid accomplishes multiple goals within a single additive, thereby limiting the increase in treatment complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively enhances elastin formation by at least 25% compared to controls lacking the second agent, improving skin elasticity and tissue health while maintaining collagen production.
Implementation Method 1
Elastin is synthesized by fibroblasts, myoblasts, and other cell types, in the form of precursor monomers called tropoelastin. Tropoelastin is secreted into the extracellular matrix, aligned along preexisting microfibrillar scaffolds, and eventually enzymatically polymerized into insoluble elastin
Implementation Method 2
Adding tannic acid to cultures that contained vitamin D3 increased the amount of tropoelastin present in the fibroblast cultures
Data Source
AI summary
Compositions, kits, and methods that can be used to improve elastin concentration are described herein. For example, pharmaceutical compositions described herein comprise a therapeutically effective amount of a first agent and a therapeutically effective amount of a second agent, wherein the first agent is tannic acid, ellagic acid, or combinations thereof, and the second agent is vitamin D, hyaluronic acid, ferulic acid, or combinations thereof.